Literature DB >> 16209453

Topography-guided custom retreatments in 27 symptomatic eyes.

A John Kanellopoulos1.   

Abstract

PURPOSE: To evaluate the use of topography-guided ablations for refractive irregularities induced by previous surgery.
METHODS: This prospective, non-comparative trial comprised 27 symptomatic eyes with a history of LASIK for myopia that underwent topography-guided treatment with the ALLEGRETTO WAVE system. Pre- and postoperative refraction, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), corneal asphericity (Q value), low contrast sensitivity, and patient's subjective assessment of improvement were measured.
RESULTS: Preoperative data were sphere -0.84 +/- 1.37 diopters (D), cylinder -1.55 +/- 0.78 D, UCVA 20/49 +/- 0.22, BSCVA 20/32 +/- 0.15, and Q value 1.46 +/- 0.79. Postoperative data at mean 6-month follow-up were: sphere -0.61 +/- 0.81 D, cylinder -0.53 +/- 0.58 D, UCVA 20/25 +/- 0.21 (P < .01), BSCVA 20/21 +/- 0.14 (P < .001), and Q value 1.07 +/- 0.89. Contrast sensitivity scores improved by 70%. No loss of BSCVA occurred in any patient.
CONCLUSIONS: Topography-guided treatments may be effective in correcting the quality of vision. It should be viewed as a possible two-step procedure due to spherical adjustment that may change refraction unpredictably.

Entities:  

Mesh:

Year:  2005        PMID: 16209453     DOI: 10.3928/1081-597X-20050901-19

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  15 in total

1.  The effect of optical zone decentration on lower- and higher-order aberrations after photorefractive keratectomy in a cat model.

Authors:  Jens Bühren; Geunyoung Yoon; Shawn Kenner; Scott MacRae; Krystel Huxlin
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

Review 2.  [Ablation profiles in corneal laser surgery. Current and future concepts].

Authors:  M Mrochen; F Hafezi; M Jankov; T Seiler
Journal:  Ophthalmologe       Date:  2006-03       Impact factor: 1.059

3.  Visual outcomes of topography-guided excimer laser surgery for treatment of patients with irregular astigmatism.

Authors:  Mohammad Ghoreishi; Afsaneh Naderi Beni; Zahra Naderi Beni
Journal:  Lasers Med Sci       Date:  2013-02-24       Impact factor: 3.161

4.  Angle kappa changes after photorefractive keratectomy for myopia.

Authors:  Siamak Zarei-Ghanavati; Hamid Gharaee; Alireza Eslampour; Mojtaba Abrishami; Soamaye Ghasemi-Moghadam
Journal:  Int Ophthalmol       Date:  2013-04-09       Impact factor: 2.031

5.  Mutual comparative analysis: a new topography-guided custom ablation protocol referencing subjective refraction to modify corneal topographic data.

Authors:  Kaiwei Cao; Lina Liu; Tao Zhang; Ting Liu; Ji Bai
Journal:  Eye Vis (Lond)       Date:  2020-07-07

6.  Topography-modified refraction (TMR): adjustment of treated cylinder amount and axis to the topography versus standard clinical refraction in myopic topography-guided LASIK.

Authors:  Anastasios John Kanellopoulos
Journal:  Clin Ophthalmol       Date:  2016-11-03

7.  Topography-Guided Refractive Astigmatism Outcomes: Predictions Comparing Three Different Programming Methods.

Authors:  R Doyle Stulting; Daniel S Durrie; Richard J Potvin; Steve H Linn; Ronald R Krueger; Mark C Lobanoff; Majid Moshirfar; Manoj V Motwani; Timothy P Lindquist; Karl G Stonecipher
Journal:  Clin Ophthalmol       Date:  2020-04-24

8.  Long-term bladeless LASIK outcomes with the FS200 Femtosecond and EX500 Excimer Laser workstation: the Refractive Suite.

Authors:  A John Kanellopoulos; George Asimellis
Journal:  Clin Ophthalmol       Date:  2013-02-21

9.  Topography-guided hyperopic and hyperopic astigmatism femtosecond laser-assisted LASIK: long-term experience with the 400 Hz eye-Q excimer platform.

Authors:  Anastasios John Kanellopoulos
Journal:  Clin Ophthalmol       Date:  2012-06-12

10.  Visual and Refractive Outcomes of Topography-guided Laser-assisted In Situ Keratomileusis in Virgin Eyes.

Authors:  Sharif Hashmani; Nauman Hashmani; Husna Haroon; Yusra Hashmi
Journal:  Cureus       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.